Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$96,274,200
-$1,127,050 QoQ
Shares Held
1,595,000
-4.8% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
4.86%
of 13F equity value
Holder Rank
#14
of 313 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. XENE ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in XENE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,274,200 | 1,595,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $97,401,250 | 1,675,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $56,025,000 | 1,250,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $56,210,000 | 1,400,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $34,430,000 | 1,100,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $44,560,271 | 1,328,175 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $45,520,490 | 1,161,237 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $45,040,106 | 1,144,021 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $38,764,910 | 994,227 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,049,510 | 837,387 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $21,187,600 | 460,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $10,262,962 | 300,438 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,324,476 | 60,376 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $3,221,100 | 90,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,971,500 | 50,000 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $2,445,600 | 80,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,701,620 | 150,500 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $764,000 | 50,000 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||